Background: Histone deacetylase 3 (HDAC3) has been studied in chronic heart failure (CHF), while the regulatory mechanism of HDAC3 on the development of CHF in regulating microRNA (miR)-26b-3p/high mobility group AT-hook 2 (HMGA2) axis has not been extensively investigated. This study aimed to probe the effects of HDAC3, miR-26b-3p and HMGA2 on CHF.
Methods: CHF rat models were established using aortic coarctation. HDAC3, miR-26b-3p and HMGA2 levels in CHF rats were examined. Thereafter, the CHF rats were injected with relative oligonucleotides and plasmids of HDAC3, miR-26b-3p and HMGA2 to detect the cardiac function, inflammatory reaction, myocardial tissue pathological changes, and cardiomyocyte apoptosis. The binding relationship between miR-26b-3p and HMGA2 and the interaction between HDAC3 and miR-26b-3p were validated.
Results: HDAC3 and HMGA2 were elevated, while miR-26b-3p was decreased in CHF rats. The reduced HDAC3 or HMGA2 or enriched miR-26b-3p attenuated cardiac dysfunction, inflammatory reaction, myocardial tissue pathological changes and cardiomyocyte apoptosis in CHF rats, while the reduction of miR-26b-3p exerted the opposite effects. Furthermore, the inhibition of the miR-26b-3p or elevation of HMGA2 reversed the effect of reduced HDAC3 on mitigating CHF progression. Mechanically, miR-26b-3p targeted HMGA2 and HDAC3 bound to miR-26-3p.
Conclusion: Downregulation of HDAC3 relieves cardiac function in CHF rats via mediating miR-26b-3p/HMGA2 axis. This study provides novel theory references and a distinct direction for the therapy strategies of CHF.
[http://dx.doi.org/10.1002/ehf2.12005] [PMID: 28834669]
[http://dx.doi.org/10.1161/JAHA.113.000670] [PMID: 24922625]
[http://dx.doi.org/10.1016/j.yjmcc.2020.09.007] [PMID: 32971072]
[http://dx.doi.org/10.1371/journal.pone.0093271] [PMID: 24751578]
[http://dx.doi.org/10.1080/15384101.2019.1635869] [PMID: 31234706]
[http://dx.doi.org/10.2174/1567202617666200506101258] [PMID: 32370714]
[http://dx.doi.org/10.18632/aging.102272] [PMID: 31541994]
[http://dx.doi.org/10.1038/s41419-020-02777-3] [PMID: 32710001]
[http://dx.doi.org/10.3390/nu12010068] [PMID: 31888029]
[http://dx.doi.org/10.1111/jcmm.15292] [PMID: 32558131]
[http://dx.doi.org/10.1159/000438864] [PMID: 26304494]
[http://dx.doi.org/10.1038/ncb1719] [PMID: 18425117]
[http://dx.doi.org/10.1080/15592294.2018.1460032] [PMID: 29613828]
[http://dx.doi.org/10.1093/cvr/cvz215] [PMID: 31397837]
[http://dx.doi.org/10.1111/cpr.12371] [PMID: 28810055]
[http://dx.doi.org/10.1016/j.ebiom.2018.11.008] [PMID: 30448225]